Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mitochondrial ribosomal protein L54 pseudogene is a non-coding DNA sequence in the human genome, related to the functional gene coding for the 39S subunit protein of mitochondrial ribosomes. While the functional MRPL54 gene encodes a protein involved in mitochondrial translation and protein synthesis within mitochondria, the pseudogene (designated by this ENSG ID) lacks the ability to produce a functional protein product. Pseudogenes of mitochondrial ribosomal proteins are generally regarded as genomic “fossils,” created through gene duplication or processing events such as retrotransposition, and are not translated into protein[1][2][3]. Pseudogenes occasionally retain sequence similarity to their parent genes but usually harbor disabling mutations (e.g., premature stop codons, frameshifts) that prevent proper expression. These sequences may sometimes be used as evolutionary markers but do not themselves actively participate in cellular processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L54 pseudogene.